With competition in the GLP-1 category increasingly cutthroat, Novo Nordisk has latched onto a real-world study that found its weight-loss drug Wegovy was better than Eli Lilly's rival Zepbound at ...

US stocks fall, as investors fret over Trump's Fed nominee, earnings, inflation Wall Street's main indexes closed lower on Friday as investors viewed President Donald Trump's nomination of former ...